XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
(In thousands)
Stock option expense$2,853 $3,517 $6,116 $7,026 
Restricted stock expense5,270 5,329 10,325 10,126 
Performance restricted stock unit expense4,726 4,377 5,872 5,012 
Total pre-tax expense$12,849 $13,223 $22,313 $22,164 
Schedule of Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Six Months Ended
June 30, 2025
Year Ended December 31, 2024
Expected volatility22.7%28.2%
Expected term (years)5.05.0
Risk-free interest rate4.07%4.31%
Expected dividend yield0.70%0.62%
Black-Scholes-Merton fair value per stock option granted$46.21 $56.42 
Schedule of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20242,140 $114.33 
Granted267 176.08 
Exercised(134)102.66 
Forfeited(27)159.79 
Outstanding at June 30, 20252,246 $121.83 6.4$133.0 
Exercisable at June 30, 20251,728 $107.70 5.6$126.7 
Schedule of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2024277 $159.71 
Granted163 176.25 
Vested(134)150.80 
Forfeited(18)167.84 
Non-vested restricted stock outstanding at June 30, 2025288 $172.72 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2024235 $150.92 
Granted93 176.08 
Performance assumption change 1
8 134.69 
Vested(92)134.69 
Forfeited(1)157.01 
Non-vested performance restricted stock outstanding at June 30, 2025243 $166.13 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.